We've found
10,106 Gastrointestinal
clinical trials
Early Stage HER2+ Breast Cancer Clinical Trial
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Early Stage HER2+ Breast Cancer Clinical Trial
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 4/4/2017
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colonic Diverticula Clinical Trial
Predictive Value of DICA in the Diverticular Disease of the Colon
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Reproductive Clinical Trial
Antibiotic Stewardship and Protection of the Developing Preterm Infant Microbiome
Status: Enrolling
Updated: 5/12/2016
Click here to add this to my saved trials
Diverticulitis Clinical Trial
DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Pancreatitis Clinical Trial
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Pancreatitis Clinical Trial
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Biliary Cirrhosis, Primary Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Biliary Cirrhosis, Primary Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Project Survival-Prospective Biomarker Discovery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
10,106 Gastrointestinal
clinical trials
Early Stage HER2+ Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Early Stage HER2+ Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Constipation, Signs and Symptoms, Digestive Clinical Trial
Updated: 12/14/2017
Phase I Pharmacokinetics and Safety Study of Naloxegol in Paediatric OIC Patients
Status: Enrolling,
Phase
I
Updated: 12/14/2017
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
Updated: 4/4/2017
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling,
Phase
IV
Updated: 4/4/2017
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diarrhoea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 8/1/2016
Retrospective Study of IBS-D Patients Previously Receiving SBI
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Updated: 12/31/1969
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Updated: 12/31/1969
A Study of Granexin Gel in the Treatment of Diabetic Foot Ulcer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 7/26/2016
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 7/26/2016
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling,
Phase
III
Updated: 7/26/2016
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colonic Diverticula Clinical Trial
Updated: 12/31/1969
Predictive Value of DICA in the Diverticular Disease of the Colon
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Reproductive Clinical Trial
Updated: 5/12/2016
Antibiotic Stewardship and Protection of the Developing Preterm Infant Microbiome
Status: Enrolling
Updated: 5/12/2016
Click here to add this to my saved trials
Diverticulitis Clinical Trial
Updated: 12/31/1969
DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Pancreatitis Clinical Trial
Updated: 12/31/1969
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Pancreatitis Clinical Trial
Updated: 12/31/1969
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Triple Combination Therapy in High Risk Crohn's Disease (CD)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Biliary Cirrhosis, Primary Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Biliary Cirrhosis, Primary Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Gastroparesis Clinical Trial
Updated: 4/26/2018
Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis
Status: Enrolling,
Phase
II
Updated: 4/26/2018
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/22/2016
A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Status: Enrolling,
Phase
III
Updated: 12/22/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Project Survival-Prospective Biomarker Discovery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials